Assessment of reperfusion injury by means of MR contrast agents in rat liver

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 3, 1997, Pages 490-494

  Reimer, Peter ^a   Allkemper, Thomas ^a   Bremer, Christoph ^a   Rummeny, Ernst J ^a   Spiegel, Hans U ^a   Balzer, Thomas ^b   Peters, Peter E ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Cell specific contrast agents; Kupffer cell activity; Liver ischemia

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBUTROL; GADOLINIUM PENTETATE; GADOXETIC ACID; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HUMAN; IMAGE ANALYSIS; KUPFFER CELL; LIVER INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; RAT; REPERFUSION INJURY;

ANALYSIS OF VARIANCE; ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; FEMALE; GADOLINIUM DTPA; IMAGE ENHANCEMENT; LIVER; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; RATS; RATS, WISTAR; REFERENCE VALUES; REPERFUSION INJURY; SENSITIVITY AND SPECIFICITY;

EID: 0031397814     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070307     Document Type: Article

References (36)

1. Bennett WF. Bova JG. Review of hepatic imaging and a problem-oriented approach to liver masses. Hepatology 1990; 12: 761-775.
2. Saini S, Stark DD, Brady TJ, Wittenberg J, Ferrucci JT. Dynamic spin-echo MRI of liver cancer using gadolinium-DTPA: animal investigation. AJR Am J Roentgenol 1986; 147:357-362.
3. Lauffer RB, Vincent AC, Padmanabhan S, et al. Hepatobiliary MR contrast agents: 5-substituted iron-EHPG derivatives. Magn Reson Med 1987; 4:582-590.
4. Brasch RC. New directions in the development of MR imaging contrast media. Radiology 1992; 183:1-11.
5. Weissleder R. Bogdanov A, Papisov M. Drug targeting in magnetic resonance imaging. Magn Reson Q 1992; 8:55-63.
6. Reimer P, Rummeny EJ, Daldrup HE, et al. Clinical results with Resovist: a phase 2 clinical trial. Radiology 1995; 195:489-496.
7. Hamm B, Staks T, Mühler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995; 195:785-792.
8. Clement O, Schouman-Claeys E. Frija G. Ferrite particles (AMI-25). Influence of cirrhosis and chemotherapy on magnetic resonance imaging of metastasis. Invest Radiol 1990; 25:61-62.
9. Elizondo G, Weissleder R, Stark DD, et al. Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology 1990; 174:797-801.
10. Pringle JH. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 1908; 48:541-544.
11. Rappaport AM, MacDonald MH, Borowy ZJ. Hepatic coma following ischemia of the liver. Surg Gynecol Obstet 1953; 97:748-762.
12. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183:59-64.
13. Weinmann H-J, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med 1992; 22:233-237.
14. Hamm B, Staks T, Taupitz M. A new superparamagnetic iron oxide contrast agent for magnetic resonance imaging. Invest Radiol 1994; 29:S87-S89.
15. Hamm B, Staks T, Taupitz M, et al. Contrast enhanced MR Imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. J Magn Reson Imaging 1994; 4:659-668.
16. Vogler H, Platzek J, Schuhmann-Giampieri G, et al. Pre-clinical evaluation of gadobutrol: a new, neutral, extracellular contrast agent for magnetic resonance imaging. Eur J Radiol 1995; 21:1-10.
17. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of Gd-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984; 142:619-625.
18. Mühler A, Clement O, Vexler V, Berthezene Y, Rosenau W, Brasch RC. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases. Radiology 1992; 184:207-213.
19. Clement O, Mühler A, Vexler VS. et al. Evaluation of radiation-induced liver injury with MR imaging: comparison of hepatocellular and reticuloendothelial contrast agents. Radiology 1992; 185:163-168.
20. Marchai G, Zhang X, Ni P, van Hecke P, Baert AL. Comparison between Gd-DTPA, Gd-EOB-DTPA. and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology. Magn Reson Imaging 1993; 11:665-674.
21. Mühler A, Freise CE, Kuwatsuru R, et al. Acute liver rejection: evaluation with cell-directed MR contrast agents in a rat transplantation model. Radiology 1993; 186:139-146.
22. Clement O, Mühler A, Vexler V, Berthezene Y, Brasch RC. Gadolinium-EOB-DTPA, a new liver specific MR contrast agent: kinetic and enhancement patterns in normal and cholestatic rats. Invest Radiol 1992; 27:612-619.
23. Clement O, Mühler A, Vexler V, et al. Comparison of Gd-EOB-DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors. J Magn Reson Imaging 1993; 3:1-7.
24. Armitage P, Berry G, eds. Statistical methods In medical research, 2nd ed. Oxford, England: Blackwell Scientific, 1987.
25. Nordlinger B, Douvin D, Javaudin L, Bloch P, Aranda A, Boschat M. An experimental study of survival after two hours of normothermic hepatic ischemia. Surg Gynecol Obstet 1980; 150:859-864.
26. Majno G, LaGatulla M. Cellular death and necrosis: chemical, physical and morphologic changes in the rat liver. Virchows Arch A Pathol Anat Histopathol 1960; 333:421-165.
27. Lemasters JJ. Thurman RG. Hypoxic, ischemic and preservation-induced injury in the liver. In: Ballet F, Thurman RG. eds. Perfused liver: clinical and basic applications. London: John Libbey, 1991; 97-120.
28. Mühler A. Clément O, Saeed M, et al. Gadolinium-ethoxybenzyl[EOB]-DTPA, a new liver-specific MR contrast agent. Absence of acute hepatotoxic, cardiovascular, or immunogenic effects. Invest Radiol 1993; 28:26.
29. Blouin A, Bolender RP, Weibel ER. Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. J Cell Biol 1977; 72:441-455.
30. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Reperfusion Injury to endothelial cells following cold ischemic storage of rat livers. Hepatology 1989; 10:292-299.
31. Caldwell-Kenkel JC, Thurman RG, Lemasters JJ. Selective loss of nonparenchymal cell viability after cold ischemic storage of rat livers. Transplantation 1988; 45:834-837.
32. Bremer C, Bradford BU, Hunt KJ, et al. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Am J Physlol 1994; 267:G630-G636.
33. Freeman M, Ashkenas J. Rees DJG, et al. An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci U S A 1990; 87:8810-8814.
34. Gassel HJ, Engemann R, Thiede A, Hamelmann H. Replacement of donor Kupffer cells by recipient cells after orthotopic liver transplantation. Transplant Proc 1987; 19:351-353.
35. Steinhoff G, Wonigkeit K, Sorg C, Behrend M, Mues B, Pichlmayr R. Patterns of macrophage immigration and differentiation in human liver grafts. Transplant Proc 1989; 21:398-400.
36. Weissleder R Reimer P, Lee AS, Wittenberg J, Brady TJ. MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors. AJR Am J Roentgenol 1990; 155: 1161-1167.